Morgan Stanley Finance LLC Launches Dual Directional Buffered PLUS Securities Linked to S&P 500 and Euro Stoxx 50

Structured Investment Framework and Dual Underlier Design

The Dual Directional Buffered PLUS securities issued by Morgan Stanley Finance LLC represent a structured investment product with exposure to two distinct market benchmarks. The securities track the State Street SPDR S&P 500 ETF, commonly known as the SPY Fund, and the EURO STOXX 50 Index, allowing investors exposure to both U.S. and European equity markets within a single instrument. The product structure ties all payments to the worst-performing underlier between these two benchmarks, meaning that depreciation in either market will determine the security's final payoff at maturity.

This dual-underlier approach creates a unique risk profile that differs from traditional diversified investments. The disclosure states that holding two underliers does not provide asset diversification benefits; rather, it concentrates risk on whichever underlier performs most poorly. Investors must understand that even if one underlier appreciates significantly, a decline in the other—particularly if it exceeds the buffer threshold—will adversely affect returns. The structure is designed for investors willing to accept principal risk in exchange for potential upside leverage and downside protection within specified parameters.

Payment Scenarios and Return Mechanics at Maturity

The securities employ a tiered payment structure that delivers different returns depending on how both underliers perform by the observation date of July 31, 2028. If the final level of each underlier exceeds its initial level, investors receive the stated principal amount plus a leveraged upside payment calculated using a leverage factor of at least 171%. This scenario rewards investors who correctly anticipated appreciation in both markets, amplifying gains through the leverage multiplier applied to the worst-performing underlier's percentage change.

In a second scenario, if the final level of either underlier is equal to or less than its initial level but both remain above their buffer levels (90% of initial levels), investors receive the stated principal amount plus a positive return. This return equals the absolute value of the percentage decline in the worst-performing underlier multiplied by the 100% absolute return participation rate, with the payment effectively capped at a positive return of 10%. The third and most adverse scenario occurs when either underlier falls below its buffer level, triggering loss of 1% for every 1% the worst performer declines beyond the 10% buffer, subject to a minimum payment of 10% of the stated principal amount. Under this scenario, investors could lose a significant portion of their initial investment.

Buffer Protection and Downside Cushion Structure

The securities incorporate a 10% buffer level for each underlier, which represents 90% of the initial level established on the strike date of July 31, 2026. The buffer mechanism provides a cushion against modest market declines, allowing investors to receive their full principal plus a modest positive return if both underliers remain above this threshold, even if they finish below their starting levels. This buffer feature is a key distinguishing characteristic of the Dual Directional Buffered PLUS product, differentiating it from standard principal-at-risk securities that offer no downside protection.

However, the buffer protection is limited and applies only to returns within the specified range. Once either underlier breaches the buffer level, losses accelerate on a one-to-one basis with further declines. The minimum payment at maturity of 10% of the stated principal amount establishes a floor, ensuring that investors cannot lose more than 90% of their initial investment, regardless of how severely the underliers decline. Still, the disclosure emphasizes that investors must be willing to accept the risk of losing a significant portion of their initial investment based on performance of either underlier, making this product suitable only for risk-tolerant investors with specific market views.

Leverage Factor and Upside Participation Terms

The leveraged upside payment mechanism amplifies returns when both underliers appreciate, with a leverage factor of at least 171% applied to the worst-performing underlier's percentage change. The filing indicates that the actual leverage factor will be determined on the pricing date of July 31, 2026, and will be disclosed in the final pricing supplement. This leverage feature allows investors to achieve outsized gains if their market outlook proves correct, potentially generating returns well in excess of the underlying indices' performance on an unleveraged basis.

The leverage benefit applies exclusively to scenarios where both underliers close above their initial levels. For investors who correctly anticipate appreciation in both U.S. and European equities, the 171% leverage factor creates meaningful return enhancement. However, this upside amplification comes paired with the downside loss exposure described in previous scenarios, illustrating the fundamental trade-off embedded in the product design: greater potential gains in favorable market environments are offset by reduced protection if market conditions deteriorate beyond the buffer threshold.

Credit Risk and Morgan Stanley Guarantee Structure

The securities are unsecured obligations of Morgan Stanley Finance LLC with a full and unconditional guarantee from Morgan Stanley, the parent company. All payments at maturity depend on Morgan Stanley's creditworthiness and ability to meet its obligations. If Morgan Stanley defaults on its obligations, investors could lose some or all of their investment, regardless of how the underlying indices perform. The disclosure explicitly notes that these securities are not secured obligations and investors will not have any security interest in or access to any underlying reference assets.

The guarantee from Morgan Stanley represents the issuer's commitment to honor the security terms, but it does not eliminate credit risk. Investors bear the counterparty risk associated with Morgan Stanley's financial stability and credit standing. The disclosure emphasizes that these securities are not deposits, savings accounts, or insured by the Federal Deposit Insurance Corporation or any other governmental agency, distinguishing them from bank products with deposit insurance protections. Investors should evaluate Morgan Stanley's creditworthiness as part of their investment decision, as the intrinsic value of the security depends on the issuer's solvency throughout the term.

Pricing, Issue Structure, and Distribution Arrangements

The securities carry an original issue price of $1,000 per security, but the estimated value on the pricing date of July 31, 2026, is approximately $980.80 per security, or within $25.00 of that estimate. This valuation discount reflects costs associated with issuing, selling, structuring, and hedging the securities, which are borne by investors. The difference between the $1,000 issue price and the estimated intrinsic value of approximately $980.80 represents the embedded costs of the structured product, including distribution fees, structuring charges, and hedging expenses.

The securities will be sold only to investors with fee-based advisory accounts, representing a restricted distribution channel. Morgan Stanley & Co., an affiliate of the issuer and a wholly owned subsidiary of Morgan Stanley, serves as the agent. The filing discloses that Morgan Stanley expects to sell all securities it purchases from MSFL to an unaffiliated dealer at a specified price for further sale to fee-based advisory clients at the $1,000 public price. Morgan Stanley & Co. will not receive a sales commission with respect to these securities, though the agent's other commissions and fees are noted on the cover of the pricing supplement, with specific dollar amounts to be disclosed in the final pricing document.

Terms, Observation Process, and Maturity Mechanics

The observation date for determining final levels of both underliers is July 31, 2028, subject to postponement for non-trading days and certain market disruption events. On this date, the closing level of each underlier will be established and compared to its initial level from July 31, 2026, to determine payment at maturity on August 3, 2028. The original issue date is August 5, 2026, establishing the timeline between pricing and actual issuance of the securities.

The filing states that definitions of "closing level" and "adjustment factor" are set forth in the General Terms section of the accompanying product supplement, indicating that additional technical specifications regarding how closing levels are calculated and whether adjustments apply are contained in the full prospectus materials. The CUSIP number for these securities is 61781GZ61, and the ISIN is US61781GZ617. The securities will not be listed on any securities exchange, meaning they are not publicly traded instruments and investors should understand liquidity constraints before purchasing. The preliminary nature of this pricing supplement indicates that final terms and specific numbers will be provided in the definitive pricing supplement at the conclusion of the pricing process.

Product Classification and Regulatory Context

The Dual Directional Buffered PLUS securities are classified as principal-at-risk securities and are part of Morgan Stanley Finance LLC's Series A Global Medium-Term Notes program. The preliminary pricing supplement indicates that the securities are being registered under registration statement numbers 333-293641 and 333-293641-01, with the supplement filed pursuant to Rule 424(b)(2) under Securities Act regulations. The associated product supplement, index supplement, tax supplement, and prospectus are all dated April 8, 2026, providing the foundational documentation for understanding the complete terms and conditions of the investment.

The disclosure includes a standard regulatory notice that the Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities or determined whether this pricing supplement and related documents are truthful or complete. Investors should review all component documents, including the product supplement, index supplement, tax supplement, and prospectus, before making any investment decision. The preliminary nature of this document underscores that final terms, including specific initial and buffer levels for each underlier and the definitive leverage factor, remain subject to finalization on the pricing date.

Risk Considerations and Investor Suitability

The securities involve risks not associated with traditional debt instruments, as emphasized in the filing's risk factors section. Investors must be willing to risk their principal in exchange for the upside leverage, absolute return participation, and buffer features, each of which applies only to limited ranges of performance. The concentration of returns on the worst-performing underlier means that diversification benefits do not apply; an investor seeking balance between U.S. and European equity exposure will not achieve that through this structure, as the worst performer will drive all returns.

Investors should carefully assess their market outlook and risk tolerance before committing capital to these securities. The product is designed for sophisticated investors who have specific views on both the U.S. S&P 500 and European equity markets, understand the mechanics of leveraged returns and buffered protection, and are comfortable with the possibility of losing substantially more than they would with traditional equity index investments. The filing's language regarding suitability emphasizes that investors must be willing to accept the risk of losing a significant portion of their initial investment based on performance of either underlier, making this a product for risk-aware participants in fee-based advisory relationships.